• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 FXR/TGR5 介导调节肠道微生物群-胆汁酸代谢途径改善非酒精性脂肪肝的亚麻籽粉作用。

Effects of flaxseed powder in improving non-alcoholic fatty liver by regulating gut microbiota-bile acids metabolic pathway through FXR/TGR5 mediating.

机构信息

Department of Public Health and Preventive Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214000, China; Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing 210009, China.

Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing 210009, China.

出版信息

Biomed Pharmacother. 2023 Jul;163:114864. doi: 10.1016/j.biopha.2023.114864. Epub 2023 May 9.

DOI:10.1016/j.biopha.2023.114864
PMID:37167728
Abstract

Non-alcoholic fatty liver disease (NAFLD) is gradually becoming one of the most common and health-endangering diseases. Flaxseed powder (FLA) is rich in α-linolenic acid, dietary fiber, lignans, and other active ingredients, which have lipid-lowering and anti-inflammatory effects. Here, we investigated whether the FLA improves host metabolism by gut bacteria modulation and further bile acid modulation in mice fed a high-fat diet. At the end of the experiment, we found that FLA can significantly reduce the body weight, body fat content, and serum TG, LDL-C, and TNF-α levels of mice, and improve liver steatosis. FLA intervention has a significant effect on preventing and regulating the gut flora disturbance caused by HFD. FLA intervention affects bile acid metabolism in the intestine and causes significant changes in functional bile acids, which can play a lipid-lowering and anti-inflammatory role by activating the intestinal Fxr- Fgfr4-Cyp7a1 and Tgr5-Tlr4-Tnfα pathways.

摘要

非酒精性脂肪性肝病(NAFLD)逐渐成为最常见和危害健康的疾病之一。亚麻籽粉(FLA)富含α-亚麻酸、膳食纤维、木脂素等活性成分,具有降血脂和抗炎作用。在这里,我们研究了 FLA 是否通过调节肠道细菌和进一步调节胆汁酸来改善高脂肪饮食喂养的小鼠的宿主代谢。实验结束时,我们发现 FLA 可显著降低高脂饮食喂养小鼠的体重、体脂含量和血清 TG、LDL-C 和 TNF-α水平,并改善肝脂肪变性。FLA 干预对预防和调节 HFD 引起的肠道菌群失调有显著效果。FLA 干预影响肠道胆汁酸代谢,导致功能胆汁酸发生显著变化,通过激活肠道 Fxr-Fgfr4-Cyp7a1 和 Tgr5-Tlr4-Tnfα途径发挥降血脂和抗炎作用。

相似文献

1
Effects of flaxseed powder in improving non-alcoholic fatty liver by regulating gut microbiota-bile acids metabolic pathway through FXR/TGR5 mediating.通过 FXR/TGR5 介导调节肠道微生物群-胆汁酸代谢途径改善非酒精性脂肪肝的亚麻籽粉作用。
Biomed Pharmacother. 2023 Jul;163:114864. doi: 10.1016/j.biopha.2023.114864. Epub 2023 May 9.
2
Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut-Liver Axis.亚麻籽粉通过调节肠道-肝脏轴的肠道微生物群和胆汁酸代谢来减轻非酒精性脂肪性肝炎。
Int J Mol Sci. 2021 Oct 8;22(19):10858. doi: 10.3390/ijms221910858.
3
Nuciferine Protects Against High-Fat Diet-Induced Hepatic Steatosis Modulation of Gut Microbiota and Bile Acid Metabolism in Rats.荷叶碱通过调节大鼠肠道微生物群和胆汁酸代谢预防高脂饮食诱导的肝脂肪变性。
J Agric Food Chem. 2022 Sep 28;70(38):12014-12028. doi: 10.1021/acs.jafc.2c04817. Epub 2022 Sep 15.
4
Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice.柑橘属植物总黄酮通过调节肠道微生物群和胆汁酸代谢减轻非酒精性脂肪性肝炎。
Biomed Pharmacother. 2021 Mar;135:111183. doi: 10.1016/j.biopha.2020.111183. Epub 2021 Jan 2.
5
Mitigation of high-fat diet-induced hepatic steatosis by thyme ( Celak) polyphenol-rich extract (TPE): insights into gut microbiota modulation and bile acid metabolism.百里香多酚丰富提取物(TPE)减轻高脂饮食诱导的肝脂肪变性:对肠道微生物群调节和胆汁酸代谢的深入了解。
Food Funct. 2024 Jul 15;15(14):7333-7347. doi: 10.1039/d3fo05235d.
6
Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.红景天苷通过调节肠道微生物群-胆汁酸-法尼醇 X 受体轴改善高脂饮食诱导的非酒精性脂肪性肝炎。
Biomed Pharmacother. 2020 Apr;124:109915. doi: 10.1016/j.biopha.2020.109915. Epub 2020 Jan 25.
7
Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway.益生菌通过肠道微生物群/FXR/FGF15 信号通路缓解高脂饮食喂养大鼠的非酒精性脂肪性肝病。
J Immunol Res. 2021 Aug 17;2021:2264737. doi: 10.1155/2021/2264737. eCollection 2021.
8
Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.蒺藜草提取物通过调节肠道微生物群和胆汁酸代谢减轻小鼠非酒精性脂肪性肝病。
J Ethnopharmacol. 2022 Aug 10;294:115333. doi: 10.1016/j.jep.2022.115333. Epub 2022 Apr 29.
9
Arabinoxylan combined with different glucans improve lipid metabolism disorder by regulating bile acid and gut microbiota in mice fed with high-fat diet.阿拉伯木聚糖与不同的葡聚糖结合通过调节高脂肪饮食喂养小鼠的胆汁酸和肠道微生物群来改善脂质代谢紊乱。
Int J Biol Macromol. 2021 Jan 31;168:279-288. doi: 10.1016/j.ijbiomac.2020.12.036. Epub 2020 Dec 10.
10
Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.回肠胆汁酸转运蛋白抑制剂通过改善非酒精性脂肪性肝病模型小鼠肠道微生物失调改善肝脂肪变性。
mBio. 2021 Aug 31;12(4):e0115521. doi: 10.1128/mBio.01155-21. Epub 2021 Jul 6.

引用本文的文献

1
Ursodeoxycholic Acid Exhibits Greater Inhibitory Effects on Cancerous HCT116 Colon Cells than on Noncancerous NCM460 Colon Cells.熊去氧胆酸对癌性HCT116结肠细胞的抑制作用比对非癌性NCM460结肠细胞的抑制作用更强。
Nutrients. 2025 Mar 19;17(6):1072. doi: 10.3390/nu17061072.
2
High-concentrate diet decreases lamb fatty acid contents by regulating bile acid composition.高浓缩日粮通过调节胆汁酸组成降低羔羊脂肪酸含量。
Food Chem X. 2024 Oct 5;24:101871. doi: 10.1016/j.fochx.2024.101871. eCollection 2024 Dec 30.
3
Therapeutic effects of composite probiotics derived from fermented camel milk on metabolic dysregulation and intestinal barrier integrity in type 2 diabetes rats.
发酵骆驼奶复合益生菌对2型糖尿病大鼠代谢失调及肠道屏障完整性的治疗作用
Front Pharmacol. 2025 Jan 7;15:1520158. doi: 10.3389/fphar.2024.1520158. eCollection 2024.
4
Regulation of bile acids and their receptor FXR in metabolic diseases.胆汁酸及其受体FXR在代谢性疾病中的调控
Front Nutr. 2024 Dec 11;11:1447878. doi: 10.3389/fnut.2024.1447878. eCollection 2024.
5
Lingguizhugan oral solution alleviates MASLD by regulating bile acids metabolism and the gut microbiota through activating FXR/TGR5 signaling pathways.苓桂术甘口服溶液通过激活FXR/TGR5信号通路调节胆汁酸代谢和肠道微生物群,从而减轻代谢相关脂肪性肝病。
Front Pharmacol. 2024 Aug 15;15:1426049. doi: 10.3389/fphar.2024.1426049. eCollection 2024.
6
Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions.揭示代谢相关脂肪性肝病中的胆固醇代谢:分子靶点与天然产物干预
Pharmaceuticals (Basel). 2024 Aug 15;17(8):1073. doi: 10.3390/ph17081073.
7
17β-Estradiol protects female rats from bilateral oophorectomy-induced nonalcoholic fatty liver disease induced by improving linoleic acid metabolism alteration and gut microbiota disturbance.17β-雌二醇通过改善亚油酸代谢改变和肠道微生物群紊乱,保护雌性大鼠免受双侧卵巢切除诱导的非酒精性脂肪性肝病。
Heliyon. 2024 Apr 2;10(7):e29013. doi: 10.1016/j.heliyon.2024.e29013. eCollection 2024 Apr 15.
8
Exploring Phytochemical Mechanisms in the Prevention of Cholesterol Dysregulation: A Review.探讨植物化学机制在预防胆固醇失调中的作用:综述。
J Agric Food Chem. 2024 Apr 3;72(13):6833-6849. doi: 10.1021/acs.jafc.3c09924. Epub 2024 Mar 22.